Form 4: Johnson & Johnson Director Nadja West Acquires Deferred Share Units

Director Nadja West acquired 1,316 Deferred Share Units (DSUs) of Johnson & Johnson on April 24, 2025, under the company's Amended and Restated Deferred Fee Plan for Directors.

Summary

• On April 24, 2025, Nadja West, a director of Johnson & Johnson, acquired 1,316 Deferred Share Units (DSUs) under the Issuer's Amended and Restated Deferred Fee Plan for Directors.
• These DSUs will be settled in cash upon termination of West's directorship, with each DSU representing the fair market value of one share of Common Stock on the settlement date.
• Following the transaction, West beneficially owns 6,572.6091 derivative securities.
• The reported transaction also includes dividend equivalent rights accrued to West on DSUs held.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, indicating a stable and well-governed company. The sentiment is neutral to slightly positive as it reflects standard corporate practices.

Positives

• The acquisition of Deferred Share Units aligns the director's interests with the long-term performance of the company.
• The Deferred Fee Plan for Directors allows for deferred compensation, potentially offering tax advantages.

Future Outlook

The Deferred Share Units will be settled in cash upon the termination of the Reporting Person's directorship.

Industry Context

Form 4 filings are standard practice for corporate insiders to report changes in their beneficial ownership of company securities, ensuring transparency and compliance with SEC regulations.

Comparison to Industry Standards

• Deferred compensation plans for directors are common among large, publicly traded companies like Johnson & Johnson.
• These plans often involve the grant of stock options, restricted stock, or deferred share units, similar to the DSUs granted to Nadja West.
• Companies like Pfizer (PFE) and Merck (MRK) also utilize deferred compensation plans for their directors as part of their overall compensation strategy.

Stakeholder Impact

• The transaction has a minimal direct impact on shareholders, as it involves deferred compensation for a director.
• The plan aligns the director's interests with the long-term performance of the company, which can indirectly benefit shareholders.

Key Dates

Keywords

Deferred Share Units, Director, Johnson & Johnson, DSU, JNJ, Beneficial Ownership, Form 4